OKYO Pharma Limited - Ordinary Shares (OKYO)
OKYO moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How OKYO actually reacts to news — the realized, point-in-time move the market made, measured across 301 labeled events over the last three years with zero look-ahead.
OKYO’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 35% | 282 |
| 30-min | 0.00% | 43% | 294 |
| 60-min | -0.32% | 42% | 298 |
| to close | 0.00% | 48% | 293 |
| Middle 50% of OKYO reactions | -2.73% to +1.54% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 301 |
Half of all OKYO Pharma Limited - Ordinary Shares news events land between -2.73% and +1.54% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How OKYO reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 10 | -2.22% | 40% | -2.55% |
| Rating reiterations | 24 | -0.27% | 50% | +0.44% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 3 further classes were observed with fewer than 10 measured events and are not published. See how OKYO ranks against every other measured name →
That’s how OKYO usually reacts — get an email when it moves on news →Email me when OKYO moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to OKYO's baseline. Nothing else.
Recent OKYO events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 6-K OKYO Pharma Ltd For: Oct 06 | SEC filing · Form 6-K | SEC EDGAR | +0.68% | -1.35% | |
| Form 6-K OKYO Pharma Ltd For: Sep 29 | SEC filing · Form 6-K | SEC EDGAR | — | -0.73% | |
| Form 6-K OKYO Pharma Ltd For: Sep 09 | SEC filing · Form 6-K | SEC EDGAR | -1.96% | -5.23% | |
| Form 6-K OKYO Pharma Ltd For: Sep 08 | SEC filing · Form 6-K | SEC EDGAR | -1.92% | -1.92% | |
| Form 20-F/A OKYO Pharma Ltd For: Mar 31 | SEC filing · Form 20-F | SEC EDGAR | +0.00% | — | |
| Form 6-K OKYO Pharma Ltd For: Jul 28 | SEC filing · Form 6-K | SEC EDGAR | -3.03% | -0.61% | |
| Form 6-K OKYO Pharma Ltd For: Jul 27 | SEC filing · Form 6-K | SEC EDGAR | -0.08% | +5.81% | |
| Form 6-K OKYO Pharma Ltd For: Jul 23 | SEC filing · Form 6-K | SEC EDGAR | -2.65% | -1.99% | |
| Form 6-K OKYO Pharma Ltd For: Jul 22 | SEC filing · Form 6-K | SEC EDGAR | -1.72% | +4.83% | |
| Form 6-K OKYO Pharma Ltd For: Jul 21 | SEC filing · Form 6-K | SEC EDGAR | -0.36% | +2.86% | |
| Form 20-F OKYO Pharma Ltd For: Mar 31 | SEC filing · Form 20-F | SEC EDGAR | +1.39% | -4.86% | |
| Form 6-K OKYO Pharma Ltd For: Jul 20 | SEC filing · Form 6-K | SEC EDGAR | +1.39% | -4.86% | |
| Form 6-K OKYO Pharma Ltd For: Jul 08 | SEC filing · Form 6-K | SEC EDGAR | +4.19% | -0.60% | |
| Form 6-K OKYO Pharma Ltd For: Jul 07 | SEC filing · Form 6-K | SEC EDGAR | -0.63% | +10.06% | |
| OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium | Press release | GlobeNewswire | -0.63% | +10.06% | |
| Form 6-K OKYO Pharma Ltd For: May 19 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +1.91% | |
| Form 6-K OKYO Pharma Ltd For: Apr 29 | SEC filing · Form 6-K | SEC EDGAR | +1.24% | -5.00% | |
| Form 6-K OKYO Pharma Ltd For: Apr 07 | SEC filing · Form 6-K | SEC EDGAR | — | -1.24% | |
| OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting | Press release | GlobeNewswire | -0.61% | -1.84% | |
| Form 6-K OKYO Pharma Ltd For: Mar 19 | SEC filing · Form 6-K | SEC EDGAR | +5.63% | +1.25% | |
| Form 6-K OKYO Pharma Ltd For: Mar 18 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +2.53% | |
| Form 6-K OKYO Pharma Ltd For: Mar 12 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -1.77% | |
| Form 6-K OKYO Pharma Ltd For: Feb 23 | SEC filing · Form 6-K | SEC EDGAR | -1.19% | -2.30% | |
| Form 6-K OKYO Pharma Ltd For: Feb 13 | SEC filing · Form 6-K | SEC EDGAR | -8.11% | -5.41% | |
| Form 6-K OKYO Pharma Ltd For: Feb 12 | SEC filing · Form 6-K | SEC EDGAR | -8.11% | -5.41% | |
| OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares | Press release | GlobeNewswire | -8.11% | -5.41% | |
| Form 6-K OKYO Pharma Ltd For: Feb 10 | SEC filing · Form 6-K | SEC EDGAR | -3.32% | -7.58% | |
| Form 6-K OKYO Pharma Ltd For: Feb 11 | SEC filing · Form 6-K | SEC EDGAR | -0.89% | -1.89% | |
| Form EFFECT OKYO Pharma Ltd | SEC filing · Form EFFECT | SEC EDGAR | -3.32% | -7.58% | |
| Form 6-K OKYO Pharma Ltd For: Feb 10 | SEC filing · Form 6-K | SEC EDGAR | -0.45% | -6.70% | |
| Form F-3 OKYO Pharma Ltd | SEC filing · Form F-3 | SEC EDGAR | -0.48% | +0.00% | |
| Form 6-K OKYO Pharma Ltd For: Jan 30 | SEC filing · Form 6-K | SEC EDGAR | -0.50% | -0.74% | |
| OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting | Press release | GlobeNewswire | -0.50% | -0.74% | |
| Form 6-K OKYO Pharma Ltd For: Jan 28 | SEC filing · Form 6-K | SEC EDGAR | +5.76% | -1.79% | |
| OKYO Pharma Announces Successful Type C Meeting with the FDA | Press release | GlobeNewswire | +5.76% | -1.79% | |
| Form 6-K OKYO Pharma Ltd For: Jan 23 | SEC filing · Form 6-K | SEC EDGAR | -3.98% | -5.13% | |
| Form 6-K OKYO Pharma Ltd For: Jan 05 | SEC filing · Form 6-K | SEC EDGAR | +2.14% | +14.29% | |
| Form 6-K OKYO Pharma Ltd For: Dec 19 | SEC filing · Form 6-K | SEC EDGAR | +5.31% | +7.98% | |
| Form 6-K OKYO Pharma Ltd For: Dec 15 | SEC filing · Form 6-K | SEC EDGAR | +0.25% | -5.50% | |
| OKYO Pharma Announces Chairman and Founder Acquires Shares | Press release | GlobeNewswire | +0.25% | -5.50% | |
| Form 6-K OKYO Pharma Ltd For: Dec 11 | SEC filing · Form 6-K | SEC EDGAR | +6.37% | +5.88% | |
| Form 6-K OKYO Pharma Ltd For: Dec 03 | SEC filing · Form 6-K | SEC EDGAR | -2.05% | -12.05% | |
| Form 6-K OKYO Pharma Ltd For: Nov 21 | SEC filing · Form 6-K | SEC EDGAR | +6.84% | +11.58% | |
| Form 6-K OKYO Pharma Ltd For: Nov 18 | SEC filing · Form 6-K | SEC EDGAR | +1.42% | +0.95% | |
| Form 6-K OKYO Pharma Ltd For: Oct 29 | SEC filing · Form 6-K | SEC EDGAR | +0.77% | +4.62% | |
| Form 6-K OKYO Pharma Ltd For: Oct 16 | SEC filing · Form 6-K | SEC EDGAR | -1.43% | +0.48% | |
| OKYO Pharma Announces Chairman and Founder Acquires Shares | Press release | GlobeNewswire | -1.43% | +0.48% | |
| Form 6-K OKYO Pharma Ltd For: Sep 22 | SEC filing · Form 6-K | SEC EDGAR | +1.24% | +11.94% | |
| Form 20-F/A OKYO Pharma Ltd For: Mar 31 | SEC filing · Form 20-F | SEC EDGAR | -1.02% | -8.87% | |
| Form 20-F OKYO Pharma Ltd For: Mar 31 | SEC filing · Form 20-F | SEC EDGAR | -3.05% | -4.41% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the OKYO section they belong to.
Where else OKYO is measured.
OKYO earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is OKYO Pharma Limited - Ordinary Shares's median reaction calculated?
Every labeled OKYO news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 301 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 43% of OKYO's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does OKYO's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.